Intravenous Delivery of miR-21 Inhibitor in Mice With Head and Neck Squamous Cell Carcinoma. Ishinaga H, Yasuma T, D'Alessandro-Gabazza CN, D'Alessandro VF, et al. Anticancer Res 2023;43:3487-3491.

Read + Share

Amedeo Smart

Independent Medical Education

Ishinaga H, Yasuma T, D'Alessandro-Gabazza CN, D'Alessandro VF, et al. Intravenous Delivery of miR-21 Inhibitor in Mice With Head and Neck Squamous Cell Carcinoma. Anticancer Res 2023;43:3487-3491.
PMID: 37500152